Copyright
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Jan 26, 2019; 11(1): 13-23
Published online Jan 26, 2019. doi: 10.4330/wjc.v11.i1.13
Published online Jan 26, 2019. doi: 10.4330/wjc.v11.i1.13
Current evidence of drug-elution therapy for infrapopliteal arterial disease
Stavros Spiliopoulos, Nikiforos Vasiniotis Kamarinos, Elias Brountzos, 2nd Radiology Department, Interventional Radiology Unit, University of Athens, Attikon University General Hospital, Athens 12461, Greece
Author contributions: Spiliopoulos S conceived the review and made critical revisions to its content; Vasiniotis Kamarinos N drafted the manuscript and made critical revisions to its content; Brountzos E drafted the manuscript and made critical revisions to its content; all authors approved the final version of the article.
Conflict-of-interest statement: The authors have no conflict of interest to declare.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Stavros Spiliopoulos, MD, PhD, Assistant Professor, 2nd Radiology Department, Interventional Radiology Unit, Attikon University Hospital, University of Athens, Attikon University General Hospital, Athens 12461, Greece, Athens 12461, Greece. stavspiliop@med.uoa.gr
Telephone: +30-210-5831832
Received: July 27, 2018
Peer-review started: July 30, 2018
First decision: October 5, 2018
Revised: October 23, 2018
Accepted: January 1, 2019
Article in press: January 1, 2019
Published online: January 26, 2019
Processing time: 183 Days and 1 Hours
Peer-review started: July 30, 2018
First decision: October 5, 2018
Revised: October 23, 2018
Accepted: January 1, 2019
Article in press: January 1, 2019
Published online: January 26, 2019
Processing time: 183 Days and 1 Hours
Core Tip
Core tip: Currently available level IA evidence justifies the use of infrapopliteal drug-eluting stents for short to medium length lesions in selected patients with specific anatomical criteria. The role of infrapopliteal drug-coated balloons remains to be determined.